Compare RDNT & MIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RDNT | MIR |
|---|---|---|
| Founded | 1985 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Industrial Machinery/Components |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.7B | 6.0B |
| IPO Year | 1986 | N/A |
| Metric | RDNT | MIR |
|---|---|---|
| Price | $74.80 | $24.53 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 7 |
| Target Price | ★ $83.60 | $28.29 |
| AVG Volume (30 Days) | 837.5K | ★ 3.3M |
| Earning Date | 11-09-2025 | 10-28-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.10 |
| Revenue | ★ $1,969,599,000.00 | $902,300,000.00 |
| Revenue This Year | $11.77 | $8.15 |
| Revenue Next Year | $10.76 | $19.02 |
| P/E Ratio | ★ N/A | $243.04 |
| Revenue Growth | ★ 11.09 | 7.82 |
| 52 Week Low | $45.00 | $12.00 |
| 52 Week High | $85.84 | $30.28 |
| Indicator | RDNT | MIR |
|---|---|---|
| Relative Strength Index (RSI) | 40.41 | 46.51 |
| Support Level | $74.96 | $24.52 |
| Resistance Level | $81.35 | $26.36 |
| Average True Range (ATR) | 2.89 | 1.03 |
| MACD | -0.68 | 0.02 |
| Stochastic Oscillator | 2.90 | 31.93 |
RadNet Inc is a national provider of diagnostic imaging services that operates in two business segments: Imaging Center segment and Digital Health segment. The Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), and fluoroscopy. The Digital Health segment develops and deploys clinical applications to enhance the interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate, and pulmonary diagnostics.
Mirion Technologies Inc provides products, services, and software that allow customers to safely leverage the power of ionizing radiation for applications that benefit the health, safety, vitality, and technological progress of the human experience. The Company manages its operations through two segments: Nuclear & Safety and Medical. The Medical segment improves the quality and safety of cancer care delivery and supports applications across medical diagnostics and practitioner safety. The Nuclear & Safety segment powers advancements in nuclear energy and critical radiation safety, measurement and analysis applications across laboratories, research and other industrial markets such as defense.